BOSTON, Sept. 30, 2024 -- Aktis Oncology, a clinical-stage biotechnology company pioneering the discovery and development of novel targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today...
Borah
Borah was formed in 2022 when the company Boragen was split into three separate companies, 5Metis, Borah and Reactive Biosciences.
